An invasive subtype of CRPC [102], the primary diagnostic criteria for NEPC include morphological features and the detection of neuroendocrine markers secreted from neuroendocrine tumor cells, including neuron-specific enolase (NSE) and chromogranin A (CgA) [103,104]. The gene discussed is ENO2; the disease is neuroendocrine neoplasm.